Texas § 266.0042 CONSENT FOR PSYCHOTROPIC MEDICATION.

Texas Statutes

§ 266.0042 — CONSENT FOR PSYCHOTROPIC MEDICATION.

Texas § 266.0042

Code FAFamily Code

This text of Texas § 266.0042 (CONSENT FOR PSYCHOTROPIC MEDICATION.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Family Code Code Ann. § 266.0042 (2026).

Text

Sec. 266.0042. CONSENT FOR PSYCHOTROPIC MEDICATION. Consent to the administration of a psychotropic medication is valid only if:

(1)the consent is given voluntarily and without undue influence; and

(2)the person authorized by law to consent for the foster child receives verbally or in writing information that describes:

(A)the specific condition to be treated;

(B)the beneficial effects on that condition expected from the medication;

(C)the probable health and mental health consequences of not consenting to the medication;

(D)the probable clinically significant side effects and risks associated with the medication; and

(E)the generally accepted alternative medications and non-pharmacological interventions to the medication, if any, and the reasons for the proposed course of treatment

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 266.0042. CONSENT FOR PSYCHOTROPIC MEDICATION. Consent to the administration of a psychotropic medication is valid only if:
(1) the consent is given voluntarily and without undue influence; and
(2) the person authorized by law to consent for the foster child receives verbally or in writing information that describes:
(A) the specific condition to be treated;
(B) the beneficial effects on that condition expected from the medication;
(C) the probable health and mental health consequences of not consenting to the medication;
(D) the probable clinically significant side effects and risks associated with the medication; and
(E) the generally accepted alternative medications and non-pharmacological interventions to the medication, if any, and the reasons for the proposed course of treatment.